K-APP (대한항균요법학회 항생제 가이드)

Thepowerbrains Co., Ltd.

Mayelana nalolu hlelo lokusebenza

Isingeniso se-Korean Antibiotics Physician's Pocket (K-APP)

Siyabonga ngokuvakashela i-APP. Siyakwamukela egameni lawo wonke amalungu e-Korean Society for Antimicrobial Therapy. Ukwethula kafushane, i-APP ingumhlahlandlela wohlelo/isizindalwazi mayelana nokusetshenziswa kwemithi elwa namagciwane eyadalwa futhi yanikezwa yi-Korean Society for Antimicrobial Therapy.

Muva nje, kusungulwe imihlahlandlela eminingi. Njengamanje kuneziqondiso ezingaba ngu-2,800 ezibhaliswe ku-Guidelines International Network kanye nemihlahlandlela engaba ngu-2,400 ebhaliswe ku-National Guideline Clearinghouse. Sikholelwa ukuthi ukuze isiqondiso sibe isiqondiso esihle kufanele sithembeke, sivuselelwe njalo, sibe nokusatshalaliswa okusabalele, futhi sisebenziseke kalula kubahlengikazi. Ngakho-ke i-Korean Society for Antimicrobial Therapy inqume ukudala nokuhlinzeka ngomhlahlandlela osuselwe kuhlelo lokusebenza/iwebhusayithi.

Kulolu hlelo lokusebenza lwemithi elwa namagciwane, sasebenzisa imihlahlandlela yasekhaya (izinkombandlela zokuzijwayeza zaseKorea) njengesisekelo, salungisa uhlelo lokusebenza nodokotela bezifo ezingathathelwana njengezithameli eziyinhloko ezihlosiwe, futhi sasihlose ukuthi kube uhlelo lokusekela izinqumo zomtholampilo olusiza odokotela benze. imiyalelo efanelekile yama-antibiotic. Ngaphezu kwalokho, senze uhlelo lokusebenza ukuthi lusetshenziswe yinoma ubani (ukufinyelela okuvulekile), lusebenze ngesikhathi esisodwa kukho kokubili isicelo kanye newebhusayithi (i-hybrid display), futhi sixhumanise lolu hlelo lokusebenza nohlelo lokusebenza lwe-PK/PD oluqukethe ulwazi oluthe xaxa lwama-antibiotic. (ukuxhumana nohlelo lokusebenza lwe-PK/PD).

Izithenjwa ezisetshenziswe ekuthuthukisweni kokuqukethwe zihlanganisa imihlahlandlela yase-Korea engu-14, imihlahlandlela yase-America engu-35, imihlahlandlela emi-5 yase-Europe, imihlahlandlela emi-4 exubile ehlanganisa i-WHO, imiqondo engama-44, kanye nezincwadi zokufunda zika-Mandell ne-Harrison. Iphepha leqiniso le-FDA noma iphakheji likasokhemisi kubhekiselwe kulo ukuze kuthuthukiswe okuqukethwe kwemithi elwa namagciwane, futhi izixhumanisi ze-Medscape zahlelelwa ukusabela okungekuhle kanye nokuqukethwe kokusebenzelana kwezidakamizwa.

Sifingqe kafushane okuqukethwe ngangokunokwenzeka ukuze sihehe ukusetshenziswa okulula. Nokho, ngenxa yalesi sinqumo kube nemikhawulo ekufakeni okuqukethwe okunemininingwane eyengeziwe. Ngaphezu kwalokho, okunye ukushoda ukuthi ngenxa yokuthi kunenombolo encane yezinkombandlela ezitholakalayo mayelana nezingane, okuqukethwe kwesicelo kumayelana nabantu abadala kuphela. Kusukela manje sizothuthukisa uhlelo lokusebenza ngezibuyekezo ukuze ziqukathe okuqukethwe okungcono nokungcono. Uhlelo lokusebenza lubuye lube nomsebenzi wempendulo lapho noma yimuphi umsebenzisi angathumela khona imibono noma iziphakamiso zakhe. Uma kukhona okuqukethwe okudinga ukuhlelwa noma ukubuyekezwa, noma uma unesiphakamiso esihle mayelana nendlela yokuchaza okuqukethwe, sicela ungangabazi ukusithumela imibono neziphakamiso zakho. Ibhodi lethu lokubuyekeza lizobuyekeza njalo futhi lisebenzise lokhu okufakiwe ngokufanele.

Siyabonga futhi ngokuvakashela i-APP. Sikumema ukuthi uhlanganyele nathi ekuthuthukiseni i-APP ibe enkulu nakakhulu.

Korean Society for Antimicrobial Therapy

Yini entsha

target 버전 변경